Narrative review / 2012
Zearalenone acts as a mycoestrogen linked to reproductive changes and breast enlargement, but epidemiological evidence on breast cancer risk is lacking.
Zearalenone (ZEN) is a non-steroidal mycoestrogen contaminating agricultural products that interacts with ERα and ERβ, resulting in changes in reproductive systems. Observations of central precocious puberty provide evidence of human harm from its use as an anabolic agent in cattle. While ZEN has been associated with breast enlargement and included in bust-enhancing supplements, epidemiological evidence regarding breast cancer risk is lacking. Work with human breast cancer cell lines shows estrogenic stimulation in ER-positive cells, yet ZEN reduced DMBA-induced breast cancers in rodents.
- Study type
- Narrative review
- Who was studied
- Humans, animals, and breast cancer cell lines
- What was measured
- Effects of zearalenone on reproduction, breast tissue, and cancer risk
THE PAPER
ZEN and the art of breast health maintenance.
Pazaiti A, Kontos M, Fentiman IS. Int J Clin Pract, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.